Detalhe da pesquisa
1.
Evaluation of markers of immunity in different metastatic immune microenvironments suggests more suppression within breast to liver metastases in breast cancer.
Breast Cancer Res Treat
; 2024 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38643348
2.
A comprehensive single-cell breast tumor atlas defines epithelial and immune heterogeneity and interactions predicting anti-PD-1 therapy response.
Cell Rep Med
; 5(5): 101511, 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38614094
3.
Digital droplet PCR analysis of organoids generated from mouse mammary tumors demonstrates proof-of-concept capture of tumor heterogeneity.
Front Cell Dev Biol
; 12: 1358583, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38827528
4.
Mimicking the breast metastatic microenvironment: characterization of a novel syngeneic model of HER2+ breast cancer.
bioRxiv
; 2024 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38352476
5.
Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial.
Nat Cancer
; 2024 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38355777
6.
Myeloid-Derived Suppressor-Cell Dynamics Control Outcomes in the Metastatic Niche.
Cancer Immunol Res
; 11(5): 614-628, 2023 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36848523
7.
Organoid generation from mouse mammary tumors captures the genetic heterogeneity of clinically relevant copy number alterations.
bioRxiv
; 2023 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36778256
8.
Breast cancer and neurotransmitters: emerging insights on mechanisms and therapeutic directions.
Oncogene
; 42(9): 627-637, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36650218
9.
Revival and Recharacterization of a Preclinical Model of Hormone-Dependent Breast Cancer to Study Immunotherapy.
Cancer Immunol Res
; 10(6): 672-673, 2022 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35544128
10.
Neurotransmitter signaling: a new frontier in colorectal cancer biology and treatment.
Oncogene
; 41(43): 4769-4778, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36182970
11.
Generating and Imaging Mouse and Human Epithelial Organoids from Normal and Tumor Mammary Tissue Without Passaging.
J Vis Exp
; (189)2022 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36440890
12.
Entinostat Decreases Immune Suppression to Promote Antitumor Responses in a HER2+ Breast Tumor Microenvironment.
Cancer Immunol Res
; 10(5): 656-669, 2022 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35201318
13.
Adopting an alternative structure for clinical trials in immunotherapy.
Expert Rev Anticancer Ther
; 21(4): 373-375, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33435760
14.
Lymph Node Immune Profiles as Predictive Biomarkers for Immune Checkpoint Inhibitor Response.
Front Mol Biosci
; 8: 674558, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34141724
15.
Clocking cancer: the circadian clock as a target in cancer therapy.
Oncogene
; 40(18): 3187-3200, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33846572
16.
Phase I Study of Entinostat and Nivolumab with or without Ipilimumab in Advanced Solid Tumors (ETCTN-9844).
Clin Cancer Res
; 27(21): 5828-5837, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34135021
17.
Evaluating the impact of age on immune checkpoint therapy biomarkers.
Cell Rep
; 36(8): 109599, 2021 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34433020
18.
Best Foot Forward: Neoadjuvant Systemic Therapy as Standard of Care in Triple-Negative and HER2-Positive Breast Cancer.
Am Soc Clin Oncol Educ Book
; 40: 1-16, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32315235
19.
Regulation of the tumor immune microenvironment and vascular normalization in TNBC murine models by a novel peptide.
Oncoimmunology
; 9(1): 1760685, 2020 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32923118
20.
Conducting a Virtual Clinical Trial in HER2-Negative Breast Cancer Using a Quantitative Systems Pharmacology Model With an Epigenetic Modulator and Immune Checkpoint Inhibitors.
Front Bioeng Biotechnol
; 8: 141, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32158754